uniQure
QURE
$4.95
Share price
5.77%
Change (1 day)
-75.97%
Change (1 year)
uniQure (QURE) - Total assets
Total assets on the balance sheet as of March 2024 : $0.77 B
According to uniQure's latest financial reports the company's total assets are $0.77 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
uniQure - Total assets on balance sheet (from 2012 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.83 B | 17.98% |
| 2022-12-31 | $0.70 B | -12.88% |
| 2021-12-31 | $0.80 B | 137.72% |
| 2020-12-31 | $0.34 B | -24.13% |
| 2019-12-31 | $0.44 B | 63.79% |
| 2018-12-31 | $0.27 B | 30.65% |
| 2017-12-31 | $0.20 B | 10.19% |
| 2016-12-31 | $0.19 B | -27.56% |
| 2015-12-31 | $0.26 B | 125.51% |
| 2014-12-31 | $0.11 B | 116.45% |
| 2013-12-31 | $53.81 M | 630.89% |
| 2012-12-31 | $7.36 M | -2.13% |
| 2011-12-31 | $7.52 M | -75.09% |
| 2010-12-31 | $30.19 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $92.98 B | 11,974.54% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 18,056.74% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $0.12 B | -83.25% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.61 B | -20.32% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.87 B | 792.50% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.95 B | 23.56% | 🇺🇸 USA |